Market Cap | ₹5.73Cr |
ROE | -53.48% |
P/E Ratio(TTM) | -5.54 |
EPS(TTM) | -3.45 |
P/B Ratio | 1.71 |
Dividend Yield | 0.00% |
Industry P/E | 38.99 |
Book Value | 11.21 |
Debt to Equity | 0.00 |
Face Value | 10 |
Parent Organisation | Brawn Biotech Limited |
BSE Symbol | 530207 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 100.21 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.19 | ||
Emcure Pharmaceuticals | NA (0.00%) | 32.70 | ||
Wockhardt | NA (0.00%) | -176.41 |